CannaPowder, Inc. (CAPD) financial statements (2021 and earlier)
Company profile
| Business Address |
20 RAOUL WALLENBERG ST., TEL AVIV,, 6971916 |
| State of Incorp. | UT |
| Fiscal Year End | December 31 |
| SIC | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 69 | 426 | 932 | 714 | 721 | 815 | ||
| Cash and cash equivalents | 69 | 426 | 707 | 606 | 721 | 815 | ||
| Short-term investments | 224 | 108 | ||||||
| Prepaid expense | 17 | 45 | 19 | 13 | 15 | 25 | ||
| Total current assets: | 86 | 471 | 951 | 727 | 736 | 840 | ||
| Noncurrent Assets | ||||||||
| TOTAL ASSETS: | 86 | 471 | 951 | 727 | 736 | 840 | ||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities, including: | 14 | 5 | 25 | 1 | ||||
| Other undisclosed accounts payable and accrued liabilities | 14 | 5 | 25 | 1 | ||||
| Other undisclosed current liabilities | (11) | |||||||
| Total current liabilities: | 3 | 5 | 25 | 1 | ||||
| Noncurrent Liabilities | ||||||||
| Other undisclosed noncurrent liabilities | 14 | |||||||
| Total noncurrent liabilities: | 14 | |||||||
| Total liabilities: | 17 | 5 | 25 | 1 | ||||
| Stockholders' equity | ||||||||
| Stockholders' equity attributable to parent, including: | 86 | 454 | 946 | 702 | 736 | 839 | ||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Additional paid in capital | 5,944 | 5,833 | 5,102 | 4,472 | 1,261 | 1,261 | ||
| Accumulated other comprehensive income (loss) | 5 | (1) | (55) | (174) | (5) | (4) | ||
| Accumulated deficit | (5,767) | (5,303) | (4,052) | (3,573) | (499) | (403) | ||
| Other undisclosed stockholders' equity attributable to parent | (96) | (75) | (48) | (23) | (22) | (15) | ||
| Total stockholders' equity: | 86 | 454 | 946 | 702 | 736 | 839 | ||
| TOTAL LIABILITIES AND EQUITY: | 86 | 471 | 951 | 727 | 736 | 840 | ||
Income statement (P&L) ($ in thousands)
| 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | ||
|---|---|---|---|---|---|---|---|
| Operating expenses | (485) | (1,250) | (489) | (3,091) | (103) | (189) | |
| Operating loss: | (485) | (1,250) | (489) | (3,091) | (103) | (189) | |
| Nonoperating income (expense) | (486) | (28) | (3) | 19 | |||
| Foreign currency transaction loss, before tax | (3) | ||||||
| Loss from continuing operations before equity method investments, income taxes: | (971) | (1,277) | (492) | (3,072) | (103) | (189) | |
| Other undisclosed income from continuing operations before income taxes | 485 | ||||||
| Loss before gain (loss) on sale of properties: | (486) | (1,277) | (492) | (3,072) | (103) | (189) | |
| Other undisclosed net income (loss) | 3 | (19) | |||||
| Net loss: | (486) | (1,277) | (489) | (3,091) | (103) | (189) | |
| Net income attributable to noncontrolling interest | 21 | ||||||
| Other undisclosed net income attributable to parent | 27 | 11 | 16 | 7 | 7 | ||
| Net loss available to common stockholders, diluted: | (464) | (1,251) | (479) | (3,075) | (96) | (182) | |
Comprehensive Income ($ in thousands)
| 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | ||
|---|---|---|---|---|---|---|---|
| Net loss: | (486) | (1,277) | (489) | (3,091) | (103) | (189) | |
| Other undisclosed comprehensive income (loss) | 4 | 119 | (191) | 6 | (4) | ||
| Comprehensive loss: | (486) | (1,273) | (371) | (3,282) | (97) | (192) | |
| Comprehensive income, net of tax, attributable to noncontrolling interest | 21 | 27 | 11 | 16 | 7 | 7 | |
| Other undisclosed comprehensive income, net of tax, attributable to parent | 6 | ||||||
| Comprehensive loss, net of tax, attributable to parent: | (458) | (1,247) | (360) | (3,266) | (90) | (185) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.